These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6371306)
1. [Prostaglandin analogs for the treatment of peptic ulcer]. Mutoh H Nihon Rinsho; 1984 Jan; 42(1):125-9. PubMed ID: 6371306 [No Abstract] [Full Text] [Related]
2. Role of prostaglandins in the control of gastric acid secretion. Peskar BM Hepatogastroenterology; 1980 Aug; 27(4):330-6. PubMed ID: 7009357 [No Abstract] [Full Text] [Related]
3. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer]. Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615 [No Abstract] [Full Text] [Related]
4. [Effects of colloidal bismuth subcitrate and aluminum hydroxide on gastric and duodenal levels of prostaglandin E2]. Estela R; Feller A; Backhouse C; Castro R; Ugarte G Rev Med Chil; 1984 Oct; 112(10):975-81. PubMed ID: 6399150 [No Abstract] [Full Text] [Related]
5. Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa. Johansson C; Kollberg B Scand J Gastroenterol Suppl; 1980; 58():93-7. PubMed ID: 6988944 [No Abstract] [Full Text] [Related]
9. [Aggression or protection of the gastric mucosa in the pathogenesis of peptic ulcer and prostaglandins and the problem of treatment]. Rybicka J Pol Arch Med Wewn; 1983 Oct; 70(4):189-96. PubMed ID: 6364053 [No Abstract] [Full Text] [Related]
13. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins]. Arakawa T; Kobayashi K Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560 [No Abstract] [Full Text] [Related]
14. Protective and therapeutic effects of gastrointestinal prostaglandins. Enprostil: a new modality. Proceedings of a symposium. November 13-14, 1985, Toronto, Canada. Am J Med; 1986 Aug; 81(2A):1-88. PubMed ID: 3092649 [No Abstract] [Full Text] [Related]
15. [Therapy and prevention of peptic lesions by prostaglandins]. Müller P; Dammann HG; Simon B Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777 [TBL] [Abstract][Full Text] [Related]
16. [Progress in clinical test methods on the protective function of the gastric mucosa; evaluation of mucosal epithelium blood flow by reflectance spectrophotometry]. Sato N; Tsuji S; Kamada T Nihon Rinsho; 1988 Jan; 46(1):175-8. PubMed ID: 3373751 [No Abstract] [Full Text] [Related]
17. [The mechanism of action of new drugs in ulcer therapy]. Simon B; Fromm T; Kather H; Kommerell B Verh Dtsch Ges Inn Med; 1978; (84):984-7. PubMed ID: 742166 [No Abstract] [Full Text] [Related]
18. [The role of prostaglandins in preventing and treating experimental stomach lesions]. Vitebskiĭ EM; Ostrovskiĭ IM; Dats MS Patol Fiziol Eksp Ter; 1988; (5):48-51. PubMed ID: 3217153 [No Abstract] [Full Text] [Related]
19. Prostaglandins for peptic ulcer: a promise unfulfilled. Hawkey CJ; Walt RP Lancet; 1986 Nov; 2(8515):1084-7. PubMed ID: 2877235 [TBL] [Abstract][Full Text] [Related]
20. Gastroprotective and ulcer healing effects of solon, a synthetic flavonoid derivative of sophoradin. Konturek SJ; Mrzozowski T; Drozdowicz D; Pawlik W; Sendur R Hepatogastroenterology; 1987 Aug; 34(4):164-70. PubMed ID: 3478294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]